Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Xiaflex

PharmaCompass

01

arrow
BIO Partnering at JPM
Not Confirmed

02

arrow
BIO Partnering at JPM
Not Confirmed

03

arrow
BIO Partnering at JPM
Not Confirmed

04

arrow
BIO Partnering at JPM
Not Confirmed

05

arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Xiaflex

arrow
BIO Partnering at JPM
Not Confirmed

Collagenase Clostridium Histolyticum

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2024 Revenue in Millions : 363

2023 Revenue in Millions : 475

Growth (%) : -24

blank

06

arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Xiaflex

arrow
BIO Partnering at JPM
Not Confirmed

Collagenase Clostridium Histolyticum

Main Therapeutic Indication : Bone and Joint Diseases

Currency : USD

2017 Revenue in Millions : 213

2016 Revenue in Millions : 190

Growth (%) : 12

blank

07

arrow
BIO Partnering at JPM
Not Confirmed

Brand Name : Xiaflex

arrow
BIO Partnering at JPM
Not Confirmed

Collagenase Clostridium Histolyticum

Main Therapeutic Indication : Bone And Joint Diseases

Currency : USD

2018 Revenue in Millions : 264

2017 Revenue in Millions : 213

Growth (%) : 24%

blank

08

arrow
BIO Partnering at JPM
Not Confirmed